Science and practice of arrhythmogenic cardiomyopathy: A paradigm shift
The clinical, genetic, and molecular paradigm of arrhythmogenic right ventricular cardiomyopathy (ARVC) has markedly progressed through the last three decades, shifting from the classical ARVC as a progressive condition characterized by fibrofatty replacement of the right ventricle,2,3,4 into a wide...
Main Authors: | Mohamed ElMaghawry, Federico Migliore, Nazar Mohammed, Despina Sanoudou, Mohammed Alhashemi |
---|---|
Format: | Article |
Language: | English |
Published: |
Magdi Yacoub Institute
2012-03-01
|
Series: | Global Cardiology Science & Practice |
Online Access: | http://www.qscience.com/doi/pdf/10.5339/gcsp.2013.8 |
Similar Items
-
A global perspective of arrhythmogenic right ventricular cardiomyopathy
by: Mohamed Elmaghawry, et al.
Published: (2012-12-01) -
Arrhythmogenic Cardiomyopathy—Current Treatment and Future Options
by: Federico Migliore, et al.
Published: (2021-06-01) -
Arrhythmogenic Cardiomyopathy
by: Blaž Podgoršek, et al.
Published: (2019-01-01) -
Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy
by: Domenico Corrado, et al.
Published: (2021-09-01) -
Arrhythmogenic Ventricular Cardiomyopathy
by: Aranyak S. Rawal, MD, et al.
Published: (2021-03-01)